USANA Health Sciences, Inc.

USNA

US90328M1071

Food Processing

Market Closed - Nyse Other stock markets 04:00:02 2024-05-13 pm EDT			5-day change	1st Jan Change
47.27 ^USD	+1.20%		+5.96%	-11.81%

May. 07	DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating	MT
May. 01	Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024

USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2021

October 26, 2021 at 04:15 pm EDT

USANA Health Sciences, Inc. provided earnings guidance for the fiscal year 2021. For the year, the company expects consolidated net sales of $1.18 billion to $1.20 billion.

Latest news about USANA Health Sciences, Inc.

DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating	May. 07	MT
Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024	May. 01
(USNA) USANA HEALTH SCIENCES Expects Fiscal Year 2024 Revenue Range $850M - $920M	Apr. 30	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 EPS Range $2.40 - $3.00	Apr. 30	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q1 Revenue $227.8M, vs. Street Est of $226.8M	Apr. 30	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q1 EPS $0.86, vs. Street Est of $0.69	Apr. 30	MT
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.	Apr. 30	CI
USANA Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	Apr. 30	CI
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing	Mar. 11	MT
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing	Mar. 11	MT
WeightWatchers shares drop as Oprah Winfrey decides to exit board	Feb. 29	RE
Transcript : USANA Health Sciences, Inc., Q4 2023 Earnings Call, Feb 07, 2024	Feb. 07
USANA Health Sciences Seeks Acquisition Opportunities	Feb. 07	CI
(USNA) USANA HEALTH SCIENCES Forecasts Q1 Revenue Range $850M - $920M	Feb. 06	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q4 EPS $0.87, vs. Street Est of $0.52	Feb. 06	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 EPS Range $2.40 - $3	Feb. 06	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 Revenue Range $850M - $920M	Feb. 06	MT
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.	Feb. 06	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 30, 2023	Feb. 06	CI
USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 06	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	Feb. 06	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 06	CI
DA Davidson Cuts USANA Health Sciences' Price Target to $53 From $62, Keeps Neutral Rating	23-10-25	MT
Transcript : USANA Health Sciences, Inc., Q3 2023 Earnings Call, Oct 25, 2023	23-10-25
USANA Health Sciences' Q3 Earnings, Sales Decline; Annual Guidance Revised	23-10-24	MT

Chart USANA Health Sciences, Inc.

Duration

Period

More charts

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Companyâs product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

Sector

Food Processing

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for USANA Health Sciences, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

47.27 USD

Average target price

55.5 USD

Spread / Average Target

+17.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
USANA HEALTH SCIENCES, INC.	-11.81%	901M
ZHEJIANG NHU COMPANY LTD.	+17.10%	8.44B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+14.30%	6.77B
THE SIMPLY GOOD FOODS COMPANY	-3.69%	3.81B
BYHEALTH CO., LTD	-7.34%	3.71B
XIAMEN KINGDOMWAY GROUP COMPANY	+1.78%	1.4B
HERBALIFE LTD.	-28.77%	1.09B
SIRIO PHARMA CO., LTD.	+18.84%	1.03B
JAMIESON WELLNESS INC.	-18.34%	785M
GRAPE KING BIO LTD	+3.85%	740M

Special Foods & Wellbeing Products